<?xml version="1.0" encoding="UTF-8"?>
<p id="Par70">We defined an HPAS predictive for clinical response to sonidegib (LDE-225) in combination with docetaxel as cases with both high HH expression in the tumor epithelium (HH Hscore &gt; 150) and intense GLI1 expression in the tumor stroma.</p>
